| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Cheng-Pei Zhu | |
| Juan Du | |||
| Hai-Tao Zhao | |||
| Shan-Shan Wang | |||
| Hao-Hai Zhang | |||
| Xin-Ting Sang | |||
| Han-Chun Huang | |||
| Xue-Shuai Wan | |||
| Ruo-Yu Miao | |||
| Liang-Cai Wu | |||
| An-Qiang Wang | |||
| Yong-Chang Zheng | |||
| P2860 | cites work | Intraductal papillary neoplasm of the bile duct | Q27012736 |
| Research progress and prospects of markers for liver cancer stem cells | Q27022262 | ||
| Risk factors for combined hepatocellular-cholangiocarcinoma: a hospital-based case-control study | Q34207893 | ||
| Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma | Q35005633 | ||
| Clinicopathological characteristics and prognostic factors in combined hepatocellular carcinoma and cholangiocarcinoma | Q35006160 | ||
| Combined hepatocellular cholangiocarcinomas; analysis of a large database | Q35176484 | ||
| Dr.VIS v2.0: an updated database of human disease-related viral integration sites in the era of high-throughput deep sequencing | Q35253538 | ||
| Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma | Q36100711 | ||
| Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database | Q36570284 | ||
| Management of combined hepatocellular and cholangiocarcinoma. | Q37088469 | ||
| Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. | Q38123870 | ||
| Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study | Q38381235 | ||
| Combined hepatocellular-cholangiocarcinoma with stem cell features, ductal plate malformation subtype: a case report and proposal of a new subtype | Q39248678 | ||
| Combined hepatocellular-cholangiocarcinoma: a case report | Q40517301 | ||
| Comparing combined hepatocellular-cholangiocarcinoma and cholangiocarcinoma: a clinicopathological study. | Q40572266 | ||
| Cholangiolocellular carcinoma with satellite nodules showing intermediate differentiation | Q41337317 | ||
| Primary combined hepatocellular-cholangiocellular sarcoma: An unusual case | Q41896548 | ||
| Combined liver cell and bile duct carcinoma. | Q41980432 | ||
| Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis | Q42216727 | ||
| Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases | Q42247130 | ||
| Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan | Q43049035 | ||
| A case report of combined hepatocellular-cholangiocarcinoma whose lymph node recurrence effectively treated with UFT | Q43206721 | ||
| Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification | Q43678782 | ||
| A 42-month disease free survival case of combined hepatocellular-cholangiocarcinoma with lymph node metastases treated with multimodal therapy | Q44010955 | ||
| Clinicopathologic significance of combined hepatocellular-cholangiocarcinoma with stem cell subtype components with reference to the expression of putative stem cell markers | Q44757237 | ||
| Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma | Q44808185 | ||
| Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype | Q48088144 | ||
| A case of combined hepatocellular-cholangiocarcinoma with favorable response to systemic chemotherapy. | Q49523608 | ||
| Long-term outcome of living-donor liver transplantation for combined hepatocellular-cholangiocarcinoma. | Q50568414 | ||
| Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma. | Q51147978 | ||
| Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. | Q53325259 | ||
| Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. | Q53366237 | ||
| Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging. | Q53479218 | ||
| Recurrence patterns of combined hepatocellular-cholangiocarcinoma on enhanced computed tomography. | Q53501947 | ||
| Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma | Q53525167 | ||
| Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. | Q53626745 | ||
| [A case of combined hepatocellular-cholangiocarcinoma with sarcomatous transformation and second primary colon cancer]. | Q53638242 | ||
| A successful resection and long-term survival of a patient with intrahepatic recurrences of combined hepatocellular-cholangiocarcinoma: report of a case. | Q53673620 | ||
| Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas. | Q55279869 | ||
| Combined hepatocellular-cholangiocarcinoma with variable sarcomatous transformation | Q69038287 | ||
| The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of Japan | Q69507027 | ||
| Expression of ABH and Lewis blood group antigens in combined hepatocellular-cholangiocarcinoma. Possible evidence for the hepatocellular origin of combined hepatocellular-cholangiocarcinoma | Q70181976 | ||
| Cytomorphology of combined hepatocellular-cholangiocarcinoma in fine needle aspirates of the liver. A report of two cases | Q71600599 | ||
| Genetic classification of combined hepatocellular-cholangiocarcinoma | Q73028597 | ||
| Combined hepatocellular-cholangiocarcinoma. Cytologic findings in four cases | Q73376584 | ||
| Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study | Q74593923 | ||
| [A case of sarcomatoid combined hepatocellular-cholangiocarcinoma] | Q75338781 | ||
| Combined hepatocellular-cholangiocarcinoma: a clinicopathological study | Q77299013 | ||
| Liver transplantation for combined hepatocellular cholangiocarcinoma | Q80256706 | ||
| Recurrent hepatocellular carcinoma is a problem we need to tackle | Q80545752 | ||
| Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy | Q80565631 | ||
| A clinical study of 11 cases of combined hepatocellular-cholangiocarcinoma Assessment of enhancement patterns on dynamics computed tomography before resection | Q81889016 | ||
| The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma | Q84113297 | ||
| Transplanted patients with combined hepatocellular-cholangiocarcinoma: now what? | Q95781449 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cholangiocarcinoma | Q124292 |
| P304 | page(s) | 4459-65 | |
| P577 | publication date | 2016-05-14 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Combined hepatocellular cholangiocarcinoma: Controversies to be addressed | |
| P478 | volume | 22 |
| Q58707841 | Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma |
| Q60928177 | Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions |
| Q90372062 | Combined hepatocellular-cholangiocarcinoma: An analysis of clinicopathological characteristics after surgery |
| Q48317424 | Human primary liver cancer-derived organoid cultures for disease modeling and drug screening |
| Q33654745 | Importance of surgical margin in the outcomes of hepatocholangiocarcinoma |
| Q92418093 | Mixed Hepatocellular Cholangiocarcinoma: A Review of Long-Term Outcomes Following Liver Transplantation |
| Q64093534 | Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis |
| Q55100898 | The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection. |
| Q54985330 | Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma. |
Search more.